Literature DB >> 3452442

Vasoactive intestinal peptide-containing nerves in Peyer's patches.

C A Ottaway1, D L Lewis, S L Asa.   

Abstract

Vasoactive intestinal peptide (VIP) is a neuropeptide that is well represented in the gut tract. Previous work has demonstrated that murine T lymphocytes have high-affinity specific receptors for VIP and has implicated their interaction with VIP in the control of T-cell migration into Peyer's patches in vivo. It was postulated that this effect was mediated by interactions in the vicinity of the specialized endothelium of the postcapillary venules of Peyer's patches. We report the localization of VIP-like immunoreactivity in mouse Peyer's patches. Immunohistochemical staining was performed with heterologous antiserum against VIP using the avidin-biotin-peroxidase complex technique. VIP positivity was present near vessels of various sizes and in close proximity to small caliber vessels lined with specialized polygonal endothelial cells. These findings provide an anatomical basis for the concept that VIP may be available as a local neurophysiological signal during the migration of lymphocytes from the blood into Peyer's patches.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3452442     DOI: 10.1016/0889-1591(87)90017-1

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  10 in total

1.  Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometry.

Authors:  Rebecca J Hermann; Travis Van der Steen; Emilie E Vomhof-Dekrey; Sejaa Al-Badrani; Steve B Wanjara; Jarrett J Failing; Jodie S Haring; Glenn P Dorsam
Journal:  J Immunol Methods       Date:  2011-11-04       Impact factor: 2.303

2.  Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells.

Authors:  Sheri Tinnell Dorsam; Emilie Vomhof-Dekrey; Rebecca J Hermann; Jodie S Haring; Travis Van der Steen; Erich Wilkerson; Goran Boskovic; James Denvir; Yulia Dementieva; Donald Primerano; Glenn Paul Dorsam
Journal:  Mol Immunol       Date:  2010-02-01       Impact factor: 4.407

3.  Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.

Authors:  Olga Bednarska; Susanna A Walter; Maite Casado-Bedmar; Magnus Ström; Eloísa Salvo-Romero; Maria Vicario; Emeran A Mayer; Åsa V Keita
Journal:  Gastroenterology       Date:  2017-07-13       Impact factor: 22.682

4.  Anatomical evidence for enteric neuroimmune interactions in Peyer's patches.

Authors:  Lucy Vulchanova; Melissa A Casey; Gwen W Crabb; William R Kennedy; David R Brown
Journal:  J Neuroimmunol       Date:  2007-03-23       Impact factor: 3.478

5.  Inhibition of vasoactive intestinal polypeptide (VIP) induces resistance to dextran sodium sulfate (DSS)-induced colitis in mice.

Authors:  John P Vu; Mulugeta Million; Muriel Larauche; Leon Luong; Joshua Norris; James A Waschek; Charalabos Pothoulakis; Joseph R Pisegna; Patrizia M Germano
Journal:  J Mol Neurosci       Date:  2014-01-07       Impact factor: 3.444

Review 6.  Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence.

Authors:  N Y Lai; K Mills; I M Chiu
Journal:  J Intern Med       Date:  2017-02-02       Impact factor: 8.989

7.  Distribution, organization and innervation of gastric MALT in conventional piglet.

Authors:  Maurizio Mazzoni; Paolo Bosi; Nadia De Sordi; Giovanna Lalatta-Costerbosa
Journal:  J Anat       Date:  2011-07-22       Impact factor: 2.610

8.  Induction of aggregation of Raji human B-lymphoblastic cells by vasoactive intestinal peptide.

Authors:  A Robichon; S P Sreedharan; J Yang; R S Shames; E C Gronroos; P P Cheng; E J Goetzl
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

9.  Morphological alteration of gut-associated lymphoid tissue after long-term total parenteral nutrition in rats.

Authors:  S Tanaka; S Miura; H Tashiro; H Serizawa; Y Hamada; M Yoshioka; M Tsuchiya
Journal:  Cell Tissue Res       Date:  1991-10       Impact factor: 5.249

Review 10.  Potential neuro-immune therapeutic targets in irritable bowel syndrome.

Authors:  Maite Casado-Bedmar; Åsa V Keita
Journal:  Therap Adv Gastroenterol       Date:  2020-04-09       Impact factor: 4.409

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.